Based on the association of TREX1 loss with poor cancer patient prognosis, which was observed in our analysis, and previously reported frequent loss of the 3p arm in tumors [54–56, 106–108], we hypothesized that TREX1 copy number alterations in malignant cells may be linked to larger gain or deletion on chromosome 3. The gene discussed is TREX1; the disease is cancer.